Patents by Inventor Ingrid RULIFSON

Ingrid RULIFSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RNAI CONSTRUCTS FOR INHIBITING PNPLA3 EXPRESSION AND METHODS OF USE THEREOF
    Publication number: 20220017906
    Abstract: The present invention relates to RNAi constructs for reducing expression of the PNPLA3 gene. Methods of using such RNAi constructs to treat or prevent liver disease, nonalcoholic fatty liver disease (NAFLD) are also described.
    Type: Application
    Filed: December 10, 2019
    Publication date: January 20, 2022
    Applicant: Amgen Inc.
    Inventors: Ingrid RULIFSON, Justin K. MURRAY, Michael OLLMANN, Oliver HOMANN
  • RNAI CONSTRUCTS FOR INHIBITING PNPLA3 EXPRESSION AND METHODS OF USE THEREOF
    Publication number: 20210139912
    Abstract: The present invention relates to RNAi constructs for reducing expression of the PNPLA3 gene. Methods of using such RNAi constructs to treat or prevent liver disease, nonalcoholic fatty liver disease (NAFLD) are also described.
    Type: Application
    Filed: December 12, 2018
    Publication date: May 13, 2021
    Applicant: AMGEN INC.
    Inventors: Ingrid RULIFSON, Justin K. MURRAY, Michael OLLMANN, Oliver HOMANN